SynthesisImmunity, inflammation and disease2024

Efficacy, safety and the lymphocyte subsets changes of low-dose IL-2 in patients with systemic lupus erythematosus: A systematic review and meta-analysis.

Qin-Yi Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.